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Abstract: Background The main objective of this study was to compare future glycemic control in children
diagnosed with type 1 diabetes mellitus (T1DM) at toddler age and preschool/school age. In addition, we
aimed to examine risk factors known to be associated with future glycated hemoglobin A1c (HbA1c) levels
in children diagnosed with T1DM. Methods This is a retrospective cohort study of 85 patients diagnosed
with T1DM at toddler age (group 1; 0-2.9 years; n = 36) or preschool/school age (group 2; 5-6.9 years;
n = 49) who were followed up at the University Children’s Hospital in Zurich for at least 10 consecutive
years or until the age of 15 years. Results The mean HbA1c level in the first year after diagnosis had
a highly predictive value about glycemic control in the following 6 years. In addition, a longer duration
of T1DM was associated with higher HbA1c values. HbA1c values did not differ significantly within
11 years after diagnosis between children in the two age groups. Neither was a difference found when
comparing the two groups in respect to their chronological age, although a trend was noted (p = 0.09).
This trend is very likely due to a longer duration of diabetes in group 1. Conclusions HbA1c level in
the first year predicts glycemic control for the next 6 years and deterioration of HbA1c values can be
noted with longer duration of T1DM. Moreover, our study demonstrated similar future glycemic control
in patients diagnosed with T1DM at toddler age and preschool/school age.
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Abstract
Background: The main objective of this study was to 
compare future glycemic control in children diagnosed 
with type 1 diabetes mellitus (T1DM) at toddler age and pre-
school/school age. In addition, we aimed to examine risk 





 levels in children diagnosed with T1DM.
Methods: This is a retrospective cohort study of 85 patients 
diagnosed with T1DM at toddler age (group 1; 0–2.9 years; 
n = 36) or preschool/school age (group 2; 5–6.9  years; 
n = 49) who were followed up at the University Children’s 
Hospital in Zurich for at least 10 consecutive years or until 
the age of 15 years.
Results: The mean HbA
1c
 level in the first year after diag-
nosis had a highly predictive value about glycemic control 
in the following 6  years. In addition, a longer duration 





values did not differ significantly within 11  years after 
diagnosis between children in the two age groups. Neither 
was a difference found when comparing the two groups in 
respect to their chronological age, although a trend was 
noted (p = 0.09). This trend is very likely due to a longer 
duration of diabetes in group 1.
Conclusions: HbA
1c
 level in the first year predicts glycemic 
control for the next 6 years and deterioration of HbA
1c
 val-
ues can be noted with longer duration of T1DM. Moreover, 
our study demonstrated similar future glycemic control 
in patients diagnosed with T1DM at toddler age and pre-
school/school age.
Keywords: diabetic ketoacidosis; HbA
1c
; type 1 diabetes 
mellitus.
Introduction
Type 1 diabetes mellitus (T1DM) results from the auto-
immune destruction of β-cells in the pancreas and the 
subsequent lack of insulin [1]. Despite advances in 
medical management, poor glycemic control in patients 
with T1DM is common and may lead to excess morbid-
ity and premature mortality [2–4]. Therefore, tight glyce-





) is essential and prevents future 
diabetic complications [5–7].
Several factors may influence future glycemic control 
or predict its future deterioration such as age at diagno-
sis, gender, socio-economic status, family structure, HbA
1c
 
level during the first year after diagnosis, duration of dia-
betes or comorbidities [8]. In addition, the presence of 
diabetic ketoacidosis at diagnosis of T1DM has been estab-
lished as risk factor predicting poor long-term glycemic 
control [9]. Moreover, there is evidence that children diag-
nosed with T1DM at an earlier age show better future gly-
cemic control than when diagnosed later in life [2, 10, 11].
Recent studies reveal an increase in patients diag-
nosed with T1DM at an age <5  years [12–15], therefore 
playing an even more important role in clinical practice 
in the future.
Only a few studies exist to date [16] which further 
examine the glycemic control of children diagnosed at an 
age <5 years. In the aforementioned study, better glycemic 
control in children diagnosed at an age of 0–4 years for the 
following 5 years was observed. However, studies assess-
ing long-term glycemic control are lacking. In the present 
study, we first aimed to examine risk factors that are 
known to be associated with future glycemic control. The 
main objective was to depict and compare long-term gly-
cemic control in children diagnosed at an age of <3 years 
(toddlers) to preschool/school children (age 5–7 years).
*Corresponding author: Daniel Konrad, MD, PhD, Children’s 
Research Centre, University Children’s Hospital, Zurich, Switzerland; 
and Department of Pediatric Endocrinology and Diabetology, 
University Children’s Hospital, Steinwiesstrasse 75, CH-8032 Zurich, 
Switzerland, Phone: +41-44-2667966,  
E-mail: daniel.konrad@kispi.uzh.ch 
Tim R.J. Aeppli: Department of Endocrinology and Diabetology, 
University Children’s Hospital, Zurich, Switzerland
Fiona L. Mahler: Department of Endocrinology and Diabetology, 
University Children’s Hospital, Zurich, Switzerland; and Department 
of Clinical Psychology, University Children’s Hospital, Zurich, 
Switzerland
Bereitgestellt von | provisional account
Angemeldet
Heruntergeladen am | 09.01.20 10:16
930      Aeppli et al.: Glycemic control of children with type 1 diabetes mellitus
Materials and methods
Subjects
The study cohort included 89 children and adolescents diagnosed 
with T1DM at an age of either <3 (group 1) or between 5 and 7 years 
(group 2) who were treated at the University Children’s Hospital in 
Zurich from 1990 to 2012. Diagnosis of T1DM was based on clinical 
features as well as the presence of islet auto-antibodies. Patients with 
monogenetic diabetes (n = 1), diabetes secondary to cystic fibrosis 
(n = 1) and children with syndromal diabetes (n = 2) were excluded. 
The main inclusion criteria were follow-up of at least 10 consecutive 
years at our institution and/or until an age of 15 years was reached. 
HbA
1c
 values of 10 patients (group 1: n = 6, group 2: n = 4) are missing 
in the first year, as T1DM in these patients was diagnosed elsewhere 
(other than our institution). The study was approved by the regional 
Ethics Committee of Zurich (number 2017-01752) and complies with 
the World Medical Association Declaration of Helsinki regarding 
ethical conduct of research involving human subjects.
Study design
A retrospective cohort study was conducted at the Department of 
Pediatric Endocrinology and Diabetology, University Children’s Hos-
pital, Zurich, Switzerland. Patients were divided into two groups 
according to age at diagnosis: 0–3  years (toddlers, group 1) and 
 5.0–6.9 years (preschool/school children, group 2).
Analysis
Patient characteristics (age at diagnosis, educational level of par-
ents, sex, comorbidities, pH at diagnosis, future insulin needs, form 
of insulin therapy, future HbA
1c
 levels) were extracted from medical 
records. Diabetic ketoacidosis (DKA) was defined as a pH at diagnosis 
of <7.30 and as blood glucose of >250 mg/dL, using the definition by 
Wolfsdorf et al. [17]. The form of insulin therapy was categorized in 
insulin pump use versus other. A random sample regarding insulin 
needs was extracted at least 10 years after diagnosis. The following 
comorbidities were extracted from patient records: hypothyroidism, 
celiac disease, cystic fibrosis and unknown syndrome.
Socioeconomic status (SES) score was calculated using a slightly 
modified version of Largo et  al. [18]. In this score, the educational 
level of mother and father are added and their jobs are taken into 
account. Higher SES score values reflect lower levels of education.
Mean HbA
1c
 levels were measured at baseline and also at each 
visit at the clinic (every 3  months) initially using the DCA 2000+ 
Analyzer (Bayer/Siemens, Leverkusen/Munich, Germany), which 
was then replaced by the DCA Vantage Analyzer (Siemens, Munich, 
 Germany). Mean HbA
1c
 level was calculated for each year and 
extracted until follow-up time of at least 10 years after diagnosis or 
an age of 15 years was reached.
Statistical analysis
Statistical analysis was conducted using SPSS 24 (IBM Corp; 
 Statistics, New York, NY, USA). The level of significance was set to 
α = 0.05. To examine the influence of sex, age at diagnosis, pH at 
diagnosis, SES score and insulin pump use on future HbA
1c
 levels, 
multiple regression analysis was conducted. Associations between 
HbA
1c
 levels during the first year and the following years were ana-
lyzed using partial correlations. To compare the different groups, 
t tests for independent samples and repeated measures analyses of 
variance (ANOVA) were calculated.
Additionally, potential covariates and confounders (sex, age at 
diagnosis, pH, duration of diabetes and SES score) were included in 
the analysis.
Results
In total, 85 patients with T1DM were included in the 
study: 36 children in group 1 (0–2.9 years; toddlers) and 
49 in group 2 (5.0–6.9 years; preschool/school children). 
Baseline characteristics of the two groups are reported 
in Table  1. Demographic and clinical characteristics did 
not differ between the groups except for age at diagnosis 
(p < 0.001).
Commonly known predictors for future glycemic 
control such as sex, age at diagnosis, pH at diagnosis 
and SES-score did not have any influence on future HbA
1c
 
levels in our study population (data not shown). Among 
others, the presence or absence of DKA at diagnosis did 
not influence future glycemic control, neither in the whole 
population (Figure 1) nor when analyzed within the two 
age groups (data not shown). Of note, mean HbA
1c
 level 
during the first year had a significant influence on future 
glycemic control during the following 6  years as shown 
for the second (p < 0.001; Figure 2A) and the sixth year 
(p < 0.001; Figure 2B). Furthermore, longer duration of 
T1DM was significantly associated with higher HbA
1c
 
values (p < 0.001; Figure 3A and B).
Long-term glycemic control did not differ significantly 
between the two age groups over an observation period of 
11 years after the diagnosis of T1DM (Figure 3A). Similarly, 
HbA
1c
 levels did not differ between the two age groups for 
a given chronological age, although a trend was noted 
(p = 0.09; Figure 3B) towards lower HbA
1c
 levels in the later 
diagnosed group 2.
Discussion
Several factors influence future glycemic control in chil-
dren and adolescence with T1DM [8, 9]. The present study 
aimed to examine whether an early age at diagnosis of 
T1DM impacts on future glycemic control. Children diag-
nosed with T1DM at toddler age and preschool/school 
age showed similar glycemic control with respect to years 
after diagnosis and to chronological age.
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Several variables which are known predictors of future 
glycemic control [8, 10, 11, 16], such as sex, age at diagno-
sis and SES score were not significant predictors of future 
HbA
1c
 levels in our study population. These results may 
suggest that our study did not have a large enough sample 
size to investigate these effects. Recently, the presence of 
DKA at diagnosis of T1DM was reported to predict poorer 
long-term glycemic control [9]. In contrast, we did not find 
any significant difference of future HbA
1c
 levels depend-
ent on the presence or absence of DKA. Compared to our 
study, older children and adolescents were included in the 
former, which may account for the observed difference. Of 
note, the mean HbA
1c
 level in the first year had a highly 
predictive value for glycemic control in the following 
6 years. This is in concordance with previous studies [19] 
and emphasizes the importance of achieving the target 
HbA
1c
 as early as possible, also in order to prevent future 
diabetic complications [6, 7]. In addition, patients who 
will have poorer future glycemic control can be targeted 
Table 1: Baseline characteristics of the study population.
 
 





Number of patients   36  49 
Age at diagnosis, years   2.07 ± 0.10  6.11 ± 0.07  <0.001
Sex
 Female   18 (50%)  22 (45%)  0.64
 Male   18 (50%)  27 (55%) 
pH at diagnosis   7.25 ± 0.02  7.31 ± 0.02  0.11
Socioeconomic status scorea   5.27 ± 0.25  5.21 ± 0.25  0.86
HbA
1c
-value 1st year   7.34 ± 0.14  7.26 ± 0.11  0.65
Insulin needs, IU/kg body weight   0.95 ± 0.05  1.01 ± 0.06  0.44
Form of therapy insulin pump   3  3  0.82
Comorbidities
 Celiac disease   5  3  0.23
 Hypothyroidism   1  2  0.75
Continuous variables are presented as mean ± SEM, categorical variables in n (%). aSocioeconomic status score ranging from 2 to 12 (2 being 
the highest socioeconomic status).


















Figure 1: The presence of DKA at the time of diagnosis does not 
impact on future glycemic control.
Mean HbA
1c
 levels of the two age groups are plotted in relation to 
diabetes duration. Non-DKA (○, n = 49), DKA (■, n = 25).





























































 value in the first year predicts future HbA
1c
 values.
Correlation between mean HbA
1c
 value in the first year after 
diagnosis and mean HbA
1c
 values in the second (A, p < 0.0001; 
n = 75) or mean HbA
1c
 values in the sixth (B, p = 0.0003; n = 75) year 
is depicted.
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earlier and additional support to these patients can be 
granted.
As reported previously [20], deterioration of glyce-
mic control with longer diabetes duration was noted in 
our study. We observed such deterioration especially 
during puberty and adolescence, a time period that is 
characterized by accelerated growth due to increased 
growth hormone release inducing insulin resistance 
as well as hormonal and psychological/social changes, 
which may negatively impact on insulin regimen adher-
ence [21, 22].
Only a few studies have so far examined and com-
pared glycemic control in children diagnosed with T1DM 
in the first years of life. Most of these studies compared 
younger (e.g. diagnosis of T1DM at 0–5 years of age) with 
older (6–12 years) age groups [2, 8] and have not focused 
on the comparison of children aged <7 years. Herein, we 
did not find a significant difference of the two different age 
groups regarding long-term glycemic control, i.e. children 
diagnosed with T1DM at toddler age showed similar HbA
1c
 
levels compared to children diagnosed at an age between 
5 and 7 years. Indeed, no difference in mean HbA
1c
 values 
between the two age groups were found up to 11  years 
after the diagnosis of T1DM. Neither was a difference 
found when comparing the two groups in respect to their 
chronological age, although a trend was noted (p = 0.09). 
This trend is very likely due to the longer duration of dia-
betes in group 1 (diagnosed at toddler age).
It is believed, that first childhood memories occur 
between the age of 3–4  years, although there is a great 
variability (13). One could argue that a missing memory 
of a life without diabetes may positively influence future 
HbA
1c
 levels. This may imply that patients enrolled in 
group 1 (toddlers) may not yet possess memories of 
a life without diabetes, whereas children included in 
group 2 (preschool/school children) do. As we found 
no statistically significant difference in future glycemic 
control between the two groups, this may indicate that 
the memory of a life without diabetes does not have an 
influence on future HbA
1c
 levels. However, prospective 
studies are needed to prove a possible correlation and to 
take each patient’s onset of first childhood memories into 
account.
This study has inherent limitations and strengths. The 
strength of this study is the long observation period (at 
least 10 consecutive years). In addition, all children were 
treated by the same staff of a single diabetes center and, 
thus, received a similar insulin injection regimen during 
the observed time period (from 1990 to 2012). However, 
insulin analogs such as insulin aspart and insulin detemir 
as well as continuous subcutaneous insulin infusion 
therapy by an insulin pump (n = 6 patients) were intro-
duced over time. Of note, insulin pump therapy was more 
commonly applied in children of the youngest age group, 
however, such difference reached no statistical signifi-
cance. The retrospective study design is clearly a weak-
ness of the present study.
In conclusion, mean HbA
1c
 level in the first year after 
T1DM diagnosis predicts glycemic control for the next 
6  years and deterioration of HbA
1c
 values can be noted 
with longer duration of T1DM. Moreover, our study dem-
onstrates similar future glycemic control in patients diag-
nosed with T1DM at toddler age (0–3 years) and preschool/
school age (5–6.9 years).
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Figure 3: Age at diagnosis does not predict future glycemic control.
Mean HbA
1c
 levels of the two age groups are plotted in relation to 
diabetes duration (A, group 1 (○) n = 30–36; group 2 (■) n = 45–49) 
or to chronological age (B, group 1 (○) n = 26–36; group 2 (■) 
n = 45–47).
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